ArticlePloS one2024

Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.

Vineeth Sukrithan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.